DSDaniela Scattolin
Daniela Scattolin
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Scattolin has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Giulia Pasello
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
5 shared publications - Daphne W. Dumoulin
Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
3 shared publications Valentina Guarneri
Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
3 shared publications- Alessandro Dal Maso
Istituto Oncologico Veneto IOV IRCCS Padova, Italy
2 shared publications - Anne-Marie Clasina Dingemans
Department of Respiratory Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands
2 shared publications - Frank W.J. Heijboer
Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by Elsevier in Lung Cancer
- Vol. 219, 109539
Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms
- 13 July 2026
- Published by Elsevier in Lung Cancer
- Vol. 219, 109539
Open AccessAnalysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms
- Open Access
- 10 April 2026
- Published by Elsevier in Lung Cancer
- Vol. 216, 109404
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study
- 10 April 2026
- Published by Elsevier in Lung Cancer
- Vol. 216, 109404
Open AccessDissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study
- Open Access
- 22 November 2025
- Published by Elsevier in Lung Cancer
- Vol. 210, 108852
Circulating microRNAs as biomarkers for risk assessment and prognostic stratification of pleural mesothelioma
- 22 November 2025
- Published by Elsevier in Lung Cancer
- Vol. 210, 108852
Open AccessCirculating microRNAs as biomarkers for risk assessment and prognostic stratification of pleural mesothelioma
- Open Access
- 25 September 2025
- Published by Elsevier in Lung Cancer
- Vol. 209, 108762
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
- 25 September 2025
- Published by Elsevier in Lung Cancer
- Vol. 209, 108762
Open AccessAdvanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
- Open Access
- 15 August 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 215, 104901
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC
- 15 August 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 215, 104901
Open AccessClinical insight on the pathway of SLFN11 as emergent biomarker in SCLC
- Open Access
- 3 July 2025
- Published by Elsevier in European Journal of Cancer
- Vol. 226, 115595
Outcome and safety of lurbinectedin as compassionate use in extensive stage small cell lung cancer: A multicentric international cohort
- 3 July 2025
- Published by Elsevier in European Journal of Cancer
- Vol. 226, 115595
Open AccessOutcome and safety of lurbinectedin as compassionate use in extensive stage small cell lung cancer: A multicentric international cohort